Publication Beamlines Strategic Pillar
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C 27 H 30 N 2 O 2 . Powder Diffraction , 1-6. 10.1017/s0885715625100869. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C 24 H 28 N 3 O 4 Cl(H 2 O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. BXDS-WLE Health
Huang, Joyce; Tian, Jing; Chung, Tzu Chun; Denton, Sam; Teng, Youchao et al. (2026). Biocompatible, Ion-Conductive Hydrogel-Filled Nerve Conduit for Peripheral Nerve Regeneration. ACS Applied Materials and Interfaces . 10.1021/acsami.5c19623. BXDS-WLE Health
Sankhe, Safiétou; Fofana, Fatoumata G.; Heiba, Walid; Ogunyemi, Oludare M.; Masisi, Kabo et al. (2025). BioStruct-Africa’s capacity building workshops as a model for advancing the emerging community of structural biologists in Africa. Communications Chemistry 8(1) . 10.1038/s42004-025-01519-w. CMCF Health
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM Health
Vara, Brandon A.; Lim, Jongwon; Moure, Casey J.; Schneider, Sebastian E.; Yeung, Charles S. et al. (2026). Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies. Journal of Medicinal Chemistry 69(4) , 4303-4316. 10.1021/acs.jmedchem.5c02997. [PDB: 9yk2] CMCF-BM Health
Van Schepdael, Matthew; Asakereh, Iman; Colautti, Jake; Gierys, Andrew J.; Sachar, Kartik et al. (2026). Biophysical characterization of Eag chaperones suggests the mechanism of effector transmembrane domain release. Nature Communications . 10.1038/s41467-025-68138-w. [PDB: 9mvg] CMCF-BM Health
Uguen, Mélanie; Shell, Devan J.; Silva, Madhushika; Deng, Yu; Li, Fengling et al. (2025). Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells. Nature Communications 16(1) . 10.1038/s41467-025-57005-3. [PDB: 9cuw, 9cux] CMCF-BM Health